Open this publication in new window or tab >>Show others...
2022 (English)In: Contact Dermatitis, ISSN 0105-1873, E-ISSN 1600-0536, Vol. 86, no 3, p. 175-188Article in journal (Refereed) Published
Abstract [en]
Background: Allergic contact dermatitis has considerable public health impact and causative haptens vary over time.
Objectives: To report the prevalence of contact allergy to allergens in the Swedish baseline series 2010 to 2017, as registered in the Swedish Patch Test Register.
Methods: Results and demographic information for patients tested with the Swedish baseline series in 2010 to 2017 were analysed.
Results: Data for 21 663 individuals (females 69%) were included. Females had significantly more positive patch tests (54% vs 40%). The reaction prevalence rates were highest for nickel sulfate (20.7%), fragrance mix I (7.1%), Myroxylon pereirae (6.9%), potassium dichromate (6.9%), cobalt chloride (6.8%), methylchloroisothiazolinone/methylisothiazolinone (MCI/MI; 6.4%), MI (3.7%), colophonium (3.5%), fragrance mix II (3.2%), and formaldehyde (3.2%). Myroxylon pereirae reaction prevalence increased from 5% in 2010 to 9% in 2017 and that for methyldibromo glutaronitrile from 3.1% to 4.6%. MCI/MI and MI reactions decreased in prevalence after 2014. Nickel reaction prevalence decreased among females aged 10 to 19 years.
Conclusions: Nickel remains the most common sensitizing agent, with reaction prevalence decreasing among females younger than 20 years. The changes in MCI/MI and MI reaction prevalence mirrored those in Europe. The register can reveal changes in contact allergy prevalence over time among patients patch tested in Sweden.
Place, publisher, year, edition, pages
John Wiley & Sons, 2022
Keywords
contact allergy, contact dermatitis, eczema, fragrance, methylchloroisothiazolinone, methylisothiazolinone, nickel, patch test, preservative, Sweden, Swedish baseline series
National Category
Dermatology and Venereal Diseases
Identifiers
urn:nbn:se:umu:diva-189622 (URN)10.1111/cod.13996 (DOI)000716808600001 ()34704261 (PubMedID)2-s2.0-85125012294 (Scopus ID)
2021-11-172021-11-172023-05-24Bibliographically approved